Likewise, there is an inflammatory endothelial dysregulation in COVID-19 patients during the acute phase, characterized by elevated levels of biomarkers of endothelial dysfunction, such as endothelin-1 (ET-1), which could produce long-term vascular involvement [2,26-28]. The gene discussed is EDN1; the disease is endothelial dysfunction.